First Report Managed Care - Home

Federal data shows that the number of Medicare patients classified as under observation has jumped sharply in recent years, and it has stirred a great deal of pushback from Medicare enrollees and advocacy groups. | Read More
An investigation by pharmacy benefit manager Prime Therapeutics suggests that 44% of members who were prescribed Xeljanz (tofacitinib citrate; Pfizer) had discontinued the rheumatoid arthritis (RA) drug just 1 year after starting it. | Read More
The New England Journal of Medicine recently invited the Democratic and Republican presidential nominees to answer how they would improve the US health care system. Hillary Clinton provided a detailed outline of her plans to increase accessibility and affordability, while Donald Trump did not respond. | Read More
A new prodrug formulation, tenofovir alafenamide, effectively treats chronic hepatitis B virus (HBV) infection with fewer bone and renal adverse effects than tenofovir disoproxil fumarate, according to two noninferiority trials. | Read More